Vogue Commercial Co. Ltd Live Quote-Ajanta Pharma Ltd | BFSL

AJANTA PHARMA LTD.

  • NSE CodeAJANTPHARMEQ
  • BSE Code532331
  • ISININE031B01049
  • IndustryPharmaceuticals

Company Information

Management

Mr. Gaurang C Shah

Co. Secretary & Compl. Officer

Mr. Arvind K Agrawal

Chief Financial Officer

Incorporation Year

31/12/1979

Registered Address

Registered Office : "Ajanta House", Charkop, Kandivli (West),
Mumbai, Maharashtra - 400067
Tel: 022-66061000
Fax: 022-66061200

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@ajantapharma.com

Website

http://www.ajantapharma.com

Listing

BSE, MCXSX, NSE

Corporate News

Ajanta Pharma Lt - Disclosure under SEBI Takeover Reg...

15-Apr-2025|3:52PM

YOGESH M. AGRAWAL has Submitted to the Exchange a copy of Disclosure under

Ajanta Pharma Lt has submitted to BSE the Shareholdin...

09-Apr-2025|6:20PM

As of March 2025, 66.26% is owned by Indian Promoters and 33.74% by Public.

Ajanta Pharma Lt - Certificate under SEBI (Depositori...

07-Apr-2025|2:21PM

Ajanta Pharma Limited has informed the Exchange about Certificate under SEB

Ajanta Pharma Lt - Trading Window-XBRL

27-Mar-2025|12:14PM

AJANTA PHARMA LIMITED has informed the Exchange about Closure of Trading Wi

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug56.06158.95
Aarti Drug357.453,262.45
Aarti Pharma733.606,648.32
Abbott India30,690.0065,214.11
Accent Micro209.75441.38

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
Nippon India ..439.210.79
UTI Flexi Cap..345.191.41
Kotak Small C..319.822.04
Nippon India ..251.633.11
HDFC Large an..235.341.01

Board Meetings

DatePurpose
30/01/2025Quarterly Results
28/10/2024Quarterly Results
30/07/2024Quarterly Results
02/05/2024Audited Results & B..
31/01/2024Quarterly Results &..